HR 5969 United States House · 119th Congress

LABEL Act

HR 5969, the LABEL Act, requires abortion-inducing drugs to include specific labeling identifying both the drug dispenser's name/address and the prescriber's name. It directly affects pharmacies, clinics, and prescribers distributing these drugs by mandating this labeling on all such products. The bill prohibits states from imposing stricter labeling rules than this federal standard. It defines "abortion-inducing drug" as one intended or used to end a pregnancy (excluding drugs for miscarriage management or ectopic pregnancy treatment). This is a labeling requirement, not a restriction on drug access or use.
Bill status in committee 1 of 4 stages cleared
Introduction
Nov 2025
Committee Review
Floor Vote
President
Introduced Nov 7, 2025 Last action Nov 7, 2025
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
2
Key actions
0
Committee
1
Nov 7, 2025
Committee
Referred to the House Committee on Energy and Commerce.
lower
Nov 7, 2025
Introduced
Introduced in House
lower
1 primary · 15 co-sponsors

Sponsors